FB 04 - Universitätsmedizin
Johannes Gutenberg-Universität Mainz
- 06131/17-9704 oder 9799 (Sekretariat)
- 06131/17-9669
Beetz, R
Enuresis und funktionelle HarninkontinenzPÄDIATRIE UP2DATE. Bd. 4. 2010 S. 335-362
Beetz, R
Enuresis und Harninkontinenz im Kindesalter, TagungsberichtKONTINENZ AKTUELL. Bd. 53. 2010 S. 7-8
Mehta, A; Clarke, JTR; Beck, M et al.
Enzyme replacement therapy for Fabry's disease ReplyLANCET. Bd. 375. H. 9725. 2010 S. 1523-1524
Harmatz, P; Yu, ZF; Giugliani, R et al.
Enzyme replacement therapy for mucopolysaccharidosis VI: evaluation of long-term pulmonary function in patients treated with recombinant human N-acetylgalactosamine 4-sulfataseJOURNAL OF INHERITED METABOLIC DISEASE. Bd. 33. H. 1. 2010 S. 51-60
Decker, C; Harmatz, P
Enzyme replacement therapy for mucopolysaccharidosis VI: Growth and pubertal development in patients treated with recombinant human N-acetylgalactosamine 4-sulfataseJournal of Pediatric Rehabilitation Medicine. Bd. 3. 2010 S. 89-100
Hahn, A; Mengel, E; Reinke, J et al.
Enzyme replacement therapy in Fabry disease - Preventing infusion-related adverse effects and securing acceptance by switching preparationMONATSSCHRIFT KINDERHEILKUNDE. Bd. 158. H. 5. 2010 S. 477-479
Mehta, A; Beck, M; Elliott, P
Enzyme replacement therapy with agalsidase alfa in patients with Fabry's disease: an analysis of registry data (vol 374, pg 1986, 2009)LANCET. Bd. 375. H. 9710. 2010 S. 200-200
Strothotte, S; Strigl-Pill, N; Grunert, B et al.
Enzyme replacement therapy with alglucosidase alfa in 44 patients with late-onset glycogen storage disease type 2: 12-month results of an observational clinical trialJOURNAL OF NEUROLOGY. Bd. 257. H. 1. 2010 S. 91-97
Musholt, TJ
Eodem vadit Endocrine Surgery: The Future Belongs to Certified Centres of CompentenceZENTRALBLATT FUR CHIRURGIE. Bd. 135. H. 3. 2010 S. 201-202
Zeißig, S
Epidemiologische Daten zu Krebserkrankungen. Wo steht was?Ärzteblatt Rheinland-Pfalz. Bd. 8. 2010 S. 17